The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(+/-)-N-{(4-Chlorophenyl)(phenyl)[4-(pyrrolidin-1-ylmethyl)phenyl]methyl}-7-chloro-4-aminoquinoline ID: ALA522052
Chembl Id: CHEMBL522052
PubChem CID: 25194348
Max Phase: Preclinical
Molecular Formula: C33H29Cl2N3
Molecular Weight: 538.52
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Clc1ccc(C(Nc2ccnc3cc(Cl)ccc23)(c2ccccc2)c2ccc(CN3CCCC3)cc2)cc1
Standard InChI: InChI=1S/C33H29Cl2N3/c34-28-14-12-27(13-15-28)33(25-6-2-1-3-7-25,26-10-8-24(9-11-26)23-38-20-4-5-21-38)37-31-18-19-36-32-22-29(35)16-17-30(31)32/h1-3,6-19,22H,4-5,20-21,23H2,(H,36,37)
Standard InChI Key: IUIFETNAAFICQI-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 538.52Molecular Weight (Monoisotopic): 537.1739AlogP: 8.54#Rotatable Bonds: 7Polar Surface Area: 28.16Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: 2HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.26CX LogP: 8.32CX LogD: 6.27Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.21Np Likeness Score: -0.99
References 1. Gemma S, Campiani G, Butini S, Joshi BP, Kukreja G, Coccone SS, Bernetti M, Persico M, Nacci V, Fiorini I, Novellino E, Taramelli D, Basilico N, Parapini S, Yardley V, Croft S, Keller-Maerki S, Rottmann M, Brun R, Coletta M, Marini S, Guiso G, Caccia S, Fattorusso C.. (2009) Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials., 52 (2): [PMID:19113955 ] [10.1021/jm801352s ]